BioCentury | Feb 12, 2021
Finance

Public listing, Phase II cancer readouts in Cyteir’s sights as it banks $80M crossover round

...in the round were Janus Henderson Investors, Acuta Capital Partners, Ally Bridge Group, Avidity Partners, Ample Plus Fund...
BioCentury | Jul 30, 2020
Finance

July 28 Quick Takes: Venture round reveals for Omega, Praxis, HaiHe; plus trio of NASDAQ IPO filings, Atsena’s debut, La Jolla-Tetraphase

...Cormorant Asset Management, Qatar Investment Authority, Irving Investors, Adage Capital Management, Verition Fund Management and Ample Plus Fund...
BioCentury | Jun 30, 2020
Finance

Syncona’s Freeline mulls IPO after crossovers back gene therapy play

...Novo Holdings A/S, Eventide Asset Management, Wellington Management Co., Cowen Healthcare Investments, Acorn Bioventures and Ample Plus Fund...
Items per page:
1 - 3 of 3
BioCentury | Feb 12, 2021
Finance

Public listing, Phase II cancer readouts in Cyteir’s sights as it banks $80M crossover round

...in the round were Janus Henderson Investors, Acuta Capital Partners, Ally Bridge Group, Avidity Partners, Ample Plus Fund...
BioCentury | Jul 30, 2020
Finance

July 28 Quick Takes: Venture round reveals for Omega, Praxis, HaiHe; plus trio of NASDAQ IPO filings, Atsena’s debut, La Jolla-Tetraphase

...Cormorant Asset Management, Qatar Investment Authority, Irving Investors, Adage Capital Management, Verition Fund Management and Ample Plus Fund...
BioCentury | Jun 30, 2020
Finance

Syncona’s Freeline mulls IPO after crossovers back gene therapy play

...Novo Holdings A/S, Eventide Asset Management, Wellington Management Co., Cowen Healthcare Investments, Acorn Bioventures and Ample Plus Fund...
Items per page:
1 - 3 of 3